Call Now
800-993-0005
      Home           About Us         Subscribe     Product Info        Media              Events       Conference Calls  
(^DJI) 0 0S&P 500 (^GSPC) 1295.22 -9.64NASDAQ Composite (^IXIC) 2778.79 -34.9Russell 2000 (^RUT) 747.21 0


iDayo™ Stock Selector: AMLN - Amylin Pharmaceuticals


iDayo™ 12/09/02: Amylin Pharmaceuticals (AMLN) - 12/09/02


For the 16 week investment period starting 12/09/02 , the iDayo™ Stock Selector rated Amylin Pharmaceuticals (AMLN) as "Heavy Accumulation" and selected AMLN as a buy for the investment period, identified as iDayo™ 12/09/02.

Company Profile for "Amylin Pharmaceuticals (AMLN)": Amylin Pharmaceuticals, Inc. is engaged in the discovery and development of potential drug candidates for the treatment of metabolic discorders.

Google Finance History for AMLN

iDayo™ 06/05/00: Amylin Pharmaceuticals (AMLN) - 06/05/00


For the 16 week investment period starting 06/05/00 , the iDayo™ Stock Selector rated Amylin Pharmaceuticals (AMLN) as "Extreme Accumulation" and selected AMLN as a buy for the investment period, identified as iDayo™ 06/05/00.

Company Profile for "Amylin Pharmaceuticals (AMLN)": Development pharmaceutical company concentrated on metabolic disorders that specializes in preclinical characterization of lead molecules.

Google Finance History for AMLN